While the debate continues about whether COVID-19 escaped from a biotech lab or emerged in a Wuhan wet market, a new study suggests the latter is much, much more likely. The research, led by an ...
Axpaxli is Ocular's main value driver, targeting a large wet AMD market with a differentiated, sustained-release TKI mechanism. DEXTENZA sales are declining, making Ocular increasingly dependent on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback